Affiliations
AffiliationsItem in Clipboard
The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An UpdateOguzhan Alagoz et al. Med Decis Making. 2018 Apr.
. 2018 Apr;38(1_suppl):99S-111S. doi: 10.1177/0272989X17711927. AffiliationsItem in Clipboard
AbstractThe University of Wisconsin Breast Cancer Epidemiology Simulation Model (UWBCS), also referred to as Model W, is a discrete-event microsimulation model that uses a systems engineering approach to replicate breast cancer epidemiology in the US over time. This population-based model simulates the lifetimes of individual women through 4 main model components: breast cancer natural history, detection, treatment, and mortality. A key feature of the UWBCS is that, in addition to specifying a population distribution in tumor growth rates, the model allows for heterogeneity in tumor behavior, with some tumors having limited malignant potential (i.e., would never become fatal in a woman's lifetime if left untreated) and some tumors being very aggressive based on metastatic spread early in their onset. The model is calibrated to Surveillance, Epidemiology, and End Results (SEER) breast cancer incidence and mortality data from 1975 to 2010, and cross-validated against data from the Wisconsin cancer reporting system. The UWBCS model generates detailed outputs including underlying disease states and observed clinical outcomes by age and calendar year, as well as costs, resource usage, and quality of life associated with screening and treatment. The UWBCS has been recently updated to account for differences in breast cancer detection, treatment, and survival by molecular subtypes (defined by ER/HER2 status), to reflect the recent advances in screening and treatment, and to consider a range of breast cancer risk factors, including breast density, race, body-mass-index, and the use of postmenopausal hormone therapy. Therefore, the model can evaluate novel screening strategies, such as risk-based screening, and can assess breast cancer outcomes by breast cancer molecular subtype. In this article, we describe the most up-to-date version of the UWBCS.
Keywords: breast cancer; incidence; screening; simulation.
FiguresFigure 1
Simulation Flowchart of the UWBCS
Figure 1
Simulation Flowchart of the UWBCS
Figure 1Simulation Flowchart of the UWBCS
Figure 2
Translation of Tumor size and…
Figure 2
Translation of Tumor size and Nodal Involvement in the Model to SEER staging
Figure 2Translation of Tumor size and Nodal Involvement in the Model to SEER staging
Figure 3. Incidence and Mortality over time…
Figure 3. Incidence and Mortality over time compared to SEER
UWBCS-best represents the outcomes obtained…
Figure 3. Incidence and Mortality over time compared to SEERUWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. (a) Age-Adjusted (30–79 years) Insitu Breast Cancer Incidence (b) Age-Adjusted (30–79 years) Localized Breast Cancer Incidence (c) Age-Adjusted (30–79 years) Regional Breast Cancer Incidence (d) Age-Adjusted (30–79 years) Distant Breast Cancer Incidence (e) Overall Age-Adjusted (30–79 years) Breast Cancer Incidence (f) Age-Adjusted (30–79 years) Breast Cancer Mortality
Figure 3. Incidence and Mortality over time…
Figure 3. Incidence and Mortality over time compared to SEER
UWBCS-best represents the outcomes obtained…
Figure 3. Incidence and Mortality over time compared to SEERUWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. (a) Age-Adjusted (30–79 years) Insitu Breast Cancer Incidence (b) Age-Adjusted (30–79 years) Localized Breast Cancer Incidence (c) Age-Adjusted (30–79 years) Regional Breast Cancer Incidence (d) Age-Adjusted (30–79 years) Distant Breast Cancer Incidence (e) Overall Age-Adjusted (30–79 years) Breast Cancer Incidence (f) Age-Adjusted (30–79 years) Breast Cancer Mortality
Figure 3. Incidence and Mortality over time…
Figure 3. Incidence and Mortality over time compared to SEER
UWBCS-best represents the outcomes obtained…
Figure 3. Incidence and Mortality over time compared to SEERUWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. (a) Age-Adjusted (30–79 years) Insitu Breast Cancer Incidence (b) Age-Adjusted (30–79 years) Localized Breast Cancer Incidence (c) Age-Adjusted (30–79 years) Regional Breast Cancer Incidence (d) Age-Adjusted (30–79 years) Distant Breast Cancer Incidence (e) Overall Age-Adjusted (30–79 years) Breast Cancer Incidence (f) Age-Adjusted (30–79 years) Breast Cancer Mortality
Figure 3. Incidence and Mortality over time…
Figure 3. Incidence and Mortality over time compared to SEER
UWBCS-best represents the outcomes obtained…
Figure 3. Incidence and Mortality over time compared to SEERUWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. (a) Age-Adjusted (30–79 years) Insitu Breast Cancer Incidence (b) Age-Adjusted (30–79 years) Localized Breast Cancer Incidence (c) Age-Adjusted (30–79 years) Regional Breast Cancer Incidence (d) Age-Adjusted (30–79 years) Distant Breast Cancer Incidence (e) Overall Age-Adjusted (30–79 years) Breast Cancer Incidence (f) Age-Adjusted (30–79 years) Breast Cancer Mortality
Figure 3. Incidence and Mortality over time…
Figure 3. Incidence and Mortality over time compared to SEER
UWBCS-best represents the outcomes obtained…
Figure 3. Incidence and Mortality over time compared to SEERUWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. (a) Age-Adjusted (30–79 years) Insitu Breast Cancer Incidence (b) Age-Adjusted (30–79 years) Localized Breast Cancer Incidence (c) Age-Adjusted (30–79 years) Regional Breast Cancer Incidence (d) Age-Adjusted (30–79 years) Distant Breast Cancer Incidence (e) Overall Age-Adjusted (30–79 years) Breast Cancer Incidence (f) Age-Adjusted (30–79 years) Breast Cancer Mortality
Figure 3. Incidence and Mortality over time…
Figure 3. Incidence and Mortality over time compared to SEER
UWBCS-best represents the outcomes obtained…
Figure 3. Incidence and Mortality over time compared to SEERUWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. (a) Age-Adjusted (30–79 years) Insitu Breast Cancer Incidence (b) Age-Adjusted (30–79 years) Localized Breast Cancer Incidence (c) Age-Adjusted (30–79 years) Regional Breast Cancer Incidence (d) Age-Adjusted (30–79 years) Distant Breast Cancer Incidence (e) Overall Age-Adjusted (30–79 years) Breast Cancer Incidence (f) Age-Adjusted (30–79 years) Breast Cancer Mortality
Figure 4. Female Breast Cancer Incidence and…
Figure 4. Female Breast Cancer Incidence and Mortality over Time in the UWBCS Compared to…
Figure 4. Female Breast Cancer Incidence and Mortality over Time in the UWBCS Compared to the Wisconsin Cancer Reporting System (WCRS) and the SEER ProgramUWBCS-best represents the outcomes obtained when the best input vector is used (a) Age-Adjusted (all ages) Breast Cancer Incidence (b) Age-Adjusted (all ages) Breast Cancer Mortality
Figure 4. Female Breast Cancer Incidence and…
Figure 4. Female Breast Cancer Incidence and Mortality over Time in the UWBCS Compared to…
Figure 4. Female Breast Cancer Incidence and Mortality over Time in the UWBCS Compared to the Wisconsin Cancer Reporting System (WCRS) and the SEER ProgramUWBCS-best represents the outcomes obtained when the best input vector is used (a) Age-Adjusted (all ages) Breast Cancer Incidence (b) Age-Adjusted (all ages) Breast Cancer Mortality
Figure 5. Survival after Diagnosis Compared to…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and Estrogen Receptor (ER) status (1990–1994)UWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. Note that some of the error bars are very narrow therefore are not clearly visible in all of the figures. (a) All cancers (40–49 years) (b) All cancers (50–59 years) (c) All cancers (60–69 years) (d) All cancers (70–84 years) (e) ER- cases (50–59 years) (f) ER- cases (50–59 years)
Figure 5. Survival after Diagnosis Compared to…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and Estrogen Receptor (ER) status (1990–1994)UWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. Note that some of the error bars are very narrow therefore are not clearly visible in all of the figures. (a) All cancers (40–49 years) (b) All cancers (50–59 years) (c) All cancers (60–69 years) (d) All cancers (70–84 years) (e) ER- cases (50–59 years) (f) ER- cases (50–59 years)
Figure 5. Survival after Diagnosis Compared to…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and Estrogen Receptor (ER) status (1990–1994)UWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. Note that some of the error bars are very narrow therefore are not clearly visible in all of the figures. (a) All cancers (40–49 years) (b) All cancers (50–59 years) (c) All cancers (60–69 years) (d) All cancers (70–84 years) (e) ER- cases (50–59 years) (f) ER- cases (50–59 years)
Figure 5. Survival after Diagnosis Compared to…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and Estrogen Receptor (ER) status (1990–1994)UWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. Note that some of the error bars are very narrow therefore are not clearly visible in all of the figures. (a) All cancers (40–49 years) (b) All cancers (50–59 years) (c) All cancers (60–69 years) (d) All cancers (70–84 years) (e) ER- cases (50–59 years) (f) ER- cases (50–59 years)
Figure 5. Survival after Diagnosis Compared to…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and Estrogen Receptor (ER) status (1990–1994)UWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. Note that some of the error bars are very narrow therefore are not clearly visible in all of the figures. (a) All cancers (40–49 years) (b) All cancers (50–59 years) (c) All cancers (60–69 years) (d) All cancers (70–84 years) (e) ER- cases (50–59 years) (f) ER- cases (50–59 years)
Figure 5. Survival after Diagnosis Compared to…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and…
Figure 5. Survival after Diagnosis Compared to SEER According to Age, Years of Follow-up and Estrogen Receptor (ER) status (1990–1994)UWBCS-best represents the outcomes obtained when the best input vector is used and UWBCS-all represents the outcomes obtained when 310 input vectors that have a score of 9 or less are used. The errors bars around UWBCS-all represent 95% “uncertainty intervals,” which are generated using the 2.5th and 97.5th percentiles’ values among 310 vectors at each annual time point for each model output. Note that some of the error bars are very narrow therefore are not clearly visible in all of the figures. (a) All cancers (40–49 years) (b) All cancers (50–59 years) (c) All cancers (60–69 years) (d) All cancers (70–84 years) (e) ER- cases (50–59 years) (f) ER- cases (50–59 years)
Similar articlesMunoz DF, Xu C, Plevritis SK. Munoz DF, et al. Med Decis Making. 2018 Apr;38(1_suppl):89S-98S. doi: 10.1177/0272989X17737508. Med Decis Making. 2018. PMID: 29554473 Free PMC article.
Munoz DF, Plevritis SK. Munoz DF, et al. Med Decis Making. 2018 Apr;38(1_suppl):32S-43S. doi: 10.1177/0272989X17743236. Med Decis Making. 2018. PMID: 29554464 Free PMC article.
Schechter CB, Near AM, Jayasekera J, Chandler Y, Mandelblatt JS. Schechter CB, et al. Med Decis Making. 2018 Apr;38(1_suppl):66S-77S. doi: 10.1177/0272989X17698685. Med Decis Making. 2018. PMID: 29554462 Free PMC article.
van den Broek JJ, van Ravesteyn NT, Heijnsdijk EA, de Koning HJ. van den Broek JJ, et al. Med Decis Making. 2018 Apr;38(1_suppl):54S-65S. doi: 10.1177/0272989X17711928. Med Decis Making. 2018. PMID: 29554469 Free PMC article.
Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL. Fryback DG, et al. J Natl Cancer Inst Monogr. 2006;(36):37-47. doi: 10.1093/jncimonographs/lgj007. J Natl Cancer Inst Monogr. 2006. PMID: 17032893
Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, van Ravesteyn NT, Schechter C, Sprague BL, Tosteson ANA, Trentham-Dietz A, Weaver D, Yaffe MJ, Yeh JM, Couch FJ, Hu C, Kraft P, Polley EC, Mandelblatt JS, Kurian AW, Robson ME; Breast Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET), in collaboration with the Breast Cancer Surveillance Consortium (BCSC), and the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium. Lowry KP, et al. JAMA Oncol. 2022 Apr 1;8(4):587-596. doi: 10.1001/jamaoncol.2021.6204. JAMA Oncol. 2022. PMID: 35175286 Free PMC article.
Yong JHE, Nadeau C, Flanagan WM, Coldman AJ, Asakawa K, Garner R, Fitzgerald N, Yaffe MJ, Miller AB. Yong JHE, et al. Curr Oncol. 2022 Mar 3;29(3):1619-1633. doi: 10.3390/curroncol29030136. Curr Oncol. 2022. PMID: 35323336 Free PMC article.
Alagoz O, Zhang Y, Arroyo N, Fernandes-Taylor S, Yang DY, Krebsbach C, Venkatesh M, Hsiao V, Davies L, Francis DO. Alagoz O, et al. Value Health. 2024 Mar;27(3):367-375. doi: 10.1016/j.jval.2023.12.007. Epub 2023 Dec 22. Value Health. 2024. PMID: 38141816 Free PMC article.
Alagoz O, Hajjar A, Chootipongchaivat S, van Ravesteyn NT, Yeh JM, Ergun MA, de Koning HJ, Chicoine B, Martin B. Alagoz O, et al. J Gen Intern Med. 2019 Nov;34(11):2374-2381. doi: 10.1007/s11606-019-05182-5. Epub 2019 Aug 5. J Gen Intern Med. 2019. PMID: 31385214 Free PMC article.
Trentham-Dietz A, Ergun MA, Alagoz O, Stout NK, Gangnon RE, Hampton JM, Dittus K, James TA, Vacek PM, Herschorn SD, Burnside ES, Tosteson ANA, Weaver DL, Sprague BL. Trentham-Dietz A, et al. Breast Cancer Res Treat. 2018 Feb;168(1):229-239. doi: 10.1007/s10549-017-4582-0. Epub 2017 Nov 28. Breast Cancer Res Treat. 2018. PMID: 29185118 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3